Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaomi Iyo

Showing results (11-20 of 330) with videos related to

Pageof 33
Sort By:
Annals of the New York Academy of Sciences|November 16, 2004
Neuromechanism of developing methamphetamine psychosis: a neuroimaging studyMasaomi Iyo, Yoshimoto Sekine, Norio Mori
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|August 6, 2013
Behavioural and psychological symptoms of dementia in an Alzheimer's disease case successfully treated with natural medicine: association with gonadotropinsTomihisa Niitsu, Hideki Okamoto, Masaomi Iyo
International Journal of Mental Health Systems|February 17, 2015
Defining outcome measures of hospitalization for assessment in the Japanese forensic mental health scheme: a Delphi studyAkihiro Shiina, Masaomi Iyo, Yoshito Igarashi
World Journal of Clinical Cases|April 23, 2021
Possible effect of blonanserin on gambling disorder: A clinical study protocol and a case reportAkihiro Shiina, Tadashi Hasegawa, Masaomi Iyo
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|October 11, 2002
[The neurobiological approaches to obsessive-compulsive disorder]Eiji Shimizu, Kenji Hashimoto, Masaomi Iyo
Brain Research. Brain Research Reviews|May 18, 2004
Critical role of brain-derived neurotrophic factor in mood disordersKenji Hashimoto, Eiji Shimizu, Masaomi Iyo
Current Pharmaceutical Design|February 1, 2012
Sigma-1 receptor agonists as therapeutic drugs for cognitive impairment in neuropsychiatric diseasesTomihisa Niitsu, Masaomi Iyo, Kenji Hashimoto
International Journal of Molecular Sciences|December 24, 2015
Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant SchizophreniaYasunori Oda, Nobuhisa Kanahara, Masaomi Iyo
Brain Research|September 15, 2009
Mithramycin protects against dopaminergic neurotoxicity in the mouse brain after administration of methamphetamineHiroko Hagiwara, Masaomi Iyo, Kenji Hashimoto
The European Journal of Neuroscience|November 1, 2006
Dietary restriction changes behaviours in brain-derived neurotrophic factor heterozygous mice: role of serotonergic systemHiroki Koizumi, Kenji Hashimoto, Masaomi Iyo
Pageof 33

Showing results (11-20 of 330) with videos related to

Sort By:
Pageof 33
Annals of the New York Academy of Sciences|November 16, 2004
Neuromechanism of developing methamphetamine psychosis: a neuroimaging studyMasaomi Iyo, Yoshimoto Sekine, Norio Mori
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|August 6, 2013
Behavioural and psychological symptoms of dementia in an Alzheimer's disease case successfully treated with natural medicine: association with gonadotropinsTomihisa Niitsu, Hideki Okamoto, Masaomi Iyo
International Journal of Mental Health Systems|February 17, 2015
Defining outcome measures of hospitalization for assessment in the Japanese forensic mental health scheme: a Delphi studyAkihiro Shiina, Masaomi Iyo, Yoshito Igarashi
World Journal of Clinical Cases|April 23, 2021
Possible effect of blonanserin on gambling disorder: A clinical study protocol and a case reportAkihiro Shiina, Tadashi Hasegawa, Masaomi Iyo
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|October 11, 2002
[The neurobiological approaches to obsessive-compulsive disorder]Eiji Shimizu, Kenji Hashimoto, Masaomi Iyo
Brain Research. Brain Research Reviews|May 18, 2004
Critical role of brain-derived neurotrophic factor in mood disordersKenji Hashimoto, Eiji Shimizu, Masaomi Iyo
Current Pharmaceutical Design|February 1, 2012
Sigma-1 receptor agonists as therapeutic drugs for cognitive impairment in neuropsychiatric diseasesTomihisa Niitsu, Masaomi Iyo, Kenji Hashimoto
International Journal of Molecular Sciences|December 24, 2015
Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant SchizophreniaYasunori Oda, Nobuhisa Kanahara, Masaomi Iyo
Brain Research|September 15, 2009
Mithramycin protects against dopaminergic neurotoxicity in the mouse brain after administration of methamphetamineHiroko Hagiwara, Masaomi Iyo, Kenji Hashimoto
The European Journal of Neuroscience|November 1, 2006
Dietary restriction changes behaviours in brain-derived neurotrophic factor heterozygous mice: role of serotonergic systemHiroki Koizumi, Kenji Hashimoto, Masaomi Iyo
Pageof 33